BENEFIT OF SEMAGLUTIDE IN SYMPTOMATIC PERIPHERAL ARTERY DISEASE BY BASELINE TYPE 2 DIABETES CHARACTERISTICS: INSIGHTS FROM STRIDE, A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL

Descargar Publicación
Specific targeting of adipose tissue metabolism is superior to caloric restriction in treating obesity-related HFpEF Tirzepatide Treatment and Associated Changes in β-Cell Function and Insulin Sensitivity in People With Obesity or Overweight With Prediabetes or Normoglycemia: A Post Hoc Analysis From the SURMOUNT-1 Trial